View in EDS

Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment response.

Saved in:
Bibliographic Details
Title: Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment response.
Authors: Canzian J; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Rozzano, Milan, Italy., Jacobs F; IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Rozzano, Milan, Italy., Floreani A; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy., Miggiano C; IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Rozzano, Milan, Italy., Tiberio P; IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Rozzano, Milan, Italy., Pozzi C; IRCCS Humanitas Research Hospital, Laboratory of Mucosal immunology and Microbiota, Rozzano, Milan, Italy., Santoro A; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Rozzano, Milan, Italy., Zambelli A; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Rozzano, Milan, Italy; ASST Papa Giovanni XXIII, Department of Medical Oncology, Bergamo, Italy., Rescigno M; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Laboratory of Mucosal immunology and Microbiota, Rozzano, Milan, Italy., De Sanctis R; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Rozzano, Milan, Italy; ASST Papa Giovanni XXIII, Department of Medical Oncology, Bergamo, Italy. Electronic address: rdesanctis@asst-pg23.it.
Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2026 Jan; Vol. 217, pp. 105035. Date of Electronic Publication: 2025 Nov 20.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0461
DOI:10.1016/j.critrevonc.2025.105035